Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
DBVT (NYSE Euronext Paris, ISIN: FR0010417345) announced the total number of shares and voting rights as of December 31, 2025 in accordance with Article 223-16 of the AMF General Regulations.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DBVT (NYSE Euronext Paris, ISIN: FR0010417345) announced the total number of shares and voting rights as of December 31, 2025 in accordance with Article 223-16 of the AMF General Regulations.
The company reported a total number of shares of 232,207,589, a total gross of voting rights of 232,207,589, and a total net of voting rights of 232,133,009 (net excludes shares without voting rights). A PDF attachment is available for the detailed statement.
Details
News Market Reaction – DBVT
On Jan 6, the first trading day after this news, DBVT closed 2.12% below the previous close.
Data tracked by StockTitan Argus for the Jan 6 session.
Key Figures
- Total shares
- 232,207,589
- Outstanding as of 12/31/2025
- Total gross voting rights
- 232,207,589
- As of 12/31/2025 under AMF Article 223-16
- Total net voting rights
- 232,133,009
- Excludes shares without voting rights, as of 12/31/2025
Historical Context
-
Positive Phase 3 VITESSE topline data for VIASKIN Peanut in children 4–7.
-
Monthly disclosure of total shares and voting rights as of Nov 30, 2025.
-
Completion of last patient visit in VITESSE Phase 3 VIASKIN Peanut trial.
-
Announcement of participation in Guggenheim Healthcare Innovation Conference.
-
Appointment of a new Chief Commercial Officer for VIASKIN Peanut strategy.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
isin financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Information Regarding the Total Number of Voting Rights and
Total Number of Shares of the Company as of December 31, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 12/31/2025 | 232,207,589 | Total gross of voting rights: 232,207,589 |
| Total net* of voting rights: 232,133,009 |
* Net total = total number of voting rights attached to shares – shares without voting rights
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.